A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder.

Trial Profile

A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Cariprazine (Primary)
  • Indications Bipolar I disorders; Manic episodes
  • Focus Registrational; Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 01 Jun 2017 Results (n=1065) of a pooled post hoc analysis of RGH-MD31, RGH-MD32 and RGH-MD33 trials, published in the Journal of Affective Disorders
    • 20 Sep 2016 Post hoc pooled analysis results of this (NCT01058668) and other trials (NCT01058096, NCT00488618, NCT00404573, NCT01104766, NCT01104779, NCT00694707) presented at the 29th Annual Congress of the European College of Neuropsychopharmacology
    • 05 Sep 2015 Pooled analysis results from this trial and other two trials published in the European Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top